NAFLD, insulin resistance associated with increased carotid intima-media thickness

Kim S-K. J Clin Endocrinol Metab. 2014; doi: 10.1210/jc.2013-4133.

  • February 13, 2014

In patients with type 2 diabetes, the prevalence of non-alcoholic fatty liver disease, or NAFLD, accompanied by insulin resistance appeared to be an independent predictor of increased carotid intima-media thickness, according to data.

“Thus, the identification of both NAFLD and insulin resistance in subjects with type 2 diabetes may be useful for CVD risk stratification,” Soo-Kyung Kim, MD, of CHA Bundang Medical Center and CHA University in Seongnam, Korea, and colleagues wrote.

The observational study included 3,226 consecutively enrolled patients with type 2 diabetes, measured for hepatic steatosis and mean carotid intima-media thickness (C-IMT).

They observed 72.7% prevalence of NAFLD; of those, 747 (23.2%) were not insulin resistance, researchers wrote.

However, there were significant differences in C-IMT and frequency of carotid atherosclerosis between groups classified by insulin resistance within the same NAFLD strata, the researchers wrote.

Specifically, C-IMT was greatest among patients with both NAFLD and insulin resistance (0.844 mm vs. 0.786), in insulin-sensitive patients without NAFLD (0.821 mm), insulin-resistant patients without NAFLD (0.807 mm), and insulin-sensitive patients with NAFLD (P for trend<.001), according to data.

“In addition, the relationship between NAFLD and/or insulin resistance and the frequency of carotid atherosclerosis disappeared after adjusting for potential confounders,” researchers wrote.

Disclosure: The researchers report no relevant financial disclosures.


Healio is intended for health care provider use and all comments will be posted at the discretion of the editors. We reserve the right not to post any comments with unsolicited information about medical devices or other products. At no time will Healio be used for medical advice to patients.